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Summary: Fibrosarcomas diagnosed during the early years of
life are called congenital/infantile fibrosarcomas. They differ
from adult fibrosarcomas because of their limited aggressive
outcome. Congenital/infantile fibrosarcomas occur most fre-
quently on the extremities. This article describes an exceptional
case of colonic congenital/infantile fibrosarcoma diagnosed in a
3-day-old baby boy. It is the third intestinal congenital/infantile
fibrosarcoma reported in the international literature. The lesion
was radically excised. Microscopic examination revealed a
densely cellular and poorly circumscribed tumor composed of
spindle cells forming interlacing fascicles with herringbone
appearance. Necrotic and hemorrhagic areas were appreciable.
Mitotic count was 2/10 high-power fields. Immunohistochem-
istry revealed that the tumor cells were positive for vimentin,
focally positive for h-caldesmon, and that they were negative for
epithelial markers, muscular markers, S-100 protein, and CD34.
The proliferation index (Mib-1) was 15%. Polymerase chain
reaction demonstrated the chromosomal translocation t(12;15)
(p13;q25). At the ultrastructural level, neoplastic cells had
fibroblastic and myofibroblastic features. The patient underwent
follow-up without adjuvant therapy. Twelve months after the
surgery, he is alive and well. Given the common indolent nature
of this tumor, it is important to avoid misdiagnoses with more
aggressive tumors. The algorithm for the diagnosis of con-
genital/infantile fibrosarcoma, especially outside the usual
localizations, should comprise morphologic, immunohistochem-
ical, molecular, and ultrastructural studies.
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F ibrosarcoma is a mesenchymal malignancy of bothadults and children representing 10% to 12% of all
soft-tissue sarcomas. The term congenital/infantile fibro-
sarcoma is used to describe the relatively rare fibrosarco-
mas diagnosed at birth or during the early years of life.
Congenital/infantile fibrosarcoma differs from adult
fibrosarcoma because of its less aggressive behavior with
a metastatic rate of about 10% and a survival rate of
more than 90%. It most frequently occurs on the
extremities and on the axial regions. Morphologically,
congenital/infantile fibrosarcoma may show high cellu-
larity, mitoses, necrosis, and cytologic atypia.1–4
Owing to the relatively indolent behavior despite the
ominous histology, congenital/infantile fibrosarcoma has
to be distinguished from other spindle-cell sarcomas of
childhood with more aggressive clinical behavior, such as
spindle-cell monophasic fibrous synovial sarcoma, rhab-
domyosarcoma, malignant peripheral nerve sheath tumor
(MPNST), and leiomyosarcoma. Furthermore, congeni-
tal/infantile fibrosarcoma also overlaps some morpholo-
gic features of gastrointestinal stromal tumors (GIST)
and of infantile myofibromatosis.
Molecular and ultrastructural studies may be useful
in the differential diagnosis. The ETV6-NTRK3 gene
fusion has been indicated as a molecular mark of
congenital fibrosarcoma.5 Ultrastructurally, neoplastic
cells show features of fibroblastic/myofibroblastic differ-
entiation.
In this article, we describe the clinical, morphologic,
immunohistochemical, molecular, and ultrastructural
features of an extraordinary case of congenital fibrosar-
coma that occurred in the right colic flexure.
CLINICAL SUMMARY
An 1800-g 3-day-old baby boy, delivered vaginally
and at term, was referred to the Neonatal Intensive
Therapy Unit of the Meyer Pediatric Hospital of Florence
because of intestinal occlusion and acute abdomen.
The presumed diagnosis of intra-abdominal mass causing
intestinal perforation was made. The pregnancy was
reported as uneventful. The mass had not been detected at
the prenatal ultrasound examinations. The baby under-
went surgery at the age of 4 days. Surgeons recognizedCopyright r 2008 by Lippincott Williams & Wilkins
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a 4-cm solid mass in the right colic flexure. Tumor rupture
was present. An ileocolonic resection with subsequent
anastomosis was made. Surgical resection of the tumor
was complete. Postoperative period was uneventful.
Because complete surgical resection was performed,
the patient underwent follow-up without adjuvant ther-
apy. Twelve months after the surgery, the patient is
healthy and disease-free by clinical and radiologic
evaluations.
PATHOLOGIC FINDINGS
Histologic, immunohistochemical, molecular, and
ultrastructural studies was executed in the Department
of Human Pathology and Oncology at Florence. The
surgical specimen, consisting of a 14-cm intestinal
segment, was routinely fixed in 10% buffered neutral
formalin. Representative samples were embedded in
paraffin. Some of the 5-mm sections of each sample were
stained with hematoxylin-eosin for the morphologic
evaluation whereas further 5-mm sections of the most
representative sample were mounted on electrostatic
slides and used for the immunohistochemical study. From
the most representative specimen were also obtained
samples for the polymerase chain reaction (PCR).
Immunohistochemical stains were performed
by standard avidin-biotin complex immunoperoxidase
method.
Total RNA was isolated from formalin-fixed,
paraffin embedded tissue sections. After dewaxing and
proteinase K digestion (1 h at 371C), the sample was
resuspended in 200-mL RNA lysis buffer RTL (RNasy
Fibrous Tissue Mini Kit-Qiagen, Hilden, Germany) and
homogenized using TissueLyser (Qiagen, Hilden, Ger-
many) in microcentrifuge tubes. Total RNA was isolated
using RNasy Fibrous Tissue Mini Kit (Qiagen, Hilden,
Germany) and successively stored at  801C.
The RNA sample (200 ng) was reverse transcribed
to cDNA using iScript Select cDNA Synthesis Kit (Bio-
Rad Laboratories, Hercules, CA), according to the
manufacturer’s protocol. In the real time reaction,
negative control (no-RNA) was performed. The PCR
assay to detect the ETV6-NTRK3 fusion transcript was
performed according to the previously described meth-
od.6 The pair of primers amplify a small 111-bp region
flanking the fusion point of the ETV6-NTRK3 gene
transcript. In brief, the reactions were carried out in a
volume of 50 mL, with 2-mM MgCl2, 0.3-mM dNTPs,
40 pmol of each primers, 1U of Taq polymerase (Applied
Biosystems), and 50 ng of cDNA template. The cycle
conditions were— 50 seconds at 941C, 30 seconds at
601C, and 60 seconds at 721C for 45 cycles.
PCR products were analyzed by 2% agarose gel
electrophoresis and visualized under ultraviolet illumina-
tion. In each PCR reaction, a no-cDNA template control
was included.
Tumour tissue fragments for electron microscopy
were fixed in 2.5% glutaraldehyde in 0.1-mol/L sodium
cacodylate buffer (pH 7.4) for 3 hours and postfixed in
1% OsO4 in 0.1-mol/L veronal acetate buffer (pH 7.4) for
1 hour. The tissue samples were stained en bloc in 2%
uranyl acetate in 50% ethanol, dehydrated in increasing
concentrations of ethanol, cleared in propylene oxide,
embedded in epoxy resin, and cut, using a diamond knife,
with a Leica Ultracut R microtome. Ultrathin serial
sections were mounted on formvar-coated Cu/Rh grids,
stained with uranyl acetate and lead citrate, and observed
with a Philips 410 LS transmission electron microscope.
Microscopic examination revealed a densely cellular
and poorly circumscribed tumor in the intestinal wall.
The tumor reached the serosal layer. The mucosal layer
was not ulcerated and was largely spared with only focal
involvement. The tumor was composed of spindle cells
forming interlacing fascicles with herringbone appearance
and small amounts of interstitial collagen. Giant cells and
calcifications were lacking. Necrotic and hemorrhagic
areas were appreciable. Mitotic count was 2/10 high-
power fields (Figs. 1, 2).
Immunohistochemical stains revealed that the
tumor cells were positive for vimentin, focally positive
for h-caldesmon, and that they were negative for keratin
(AE1/AE3), epithelial membrane antigen, muscle-specific
actin (HHF35), desmin, a-smooth muscle actin, S-100
protein, and CD34. The proliferation index, as deter-
mined at the immunohistochemistry estimating the
percentage of the Mib-1 positive neoplastic cells in the
total tumoral cells in the most positive areas, was 15%
(Fig. 3).
PCR evaluation demonstrated that the lesion
contained the chromosomal translocation t(12;15)
(p13;q25) (Fig. 4).
At the ultrastructural level, neoplastic cells had a
spindle shape, with oval, often indented nucleus and were
embedded in abundant extracellular matrix-containing
collagen fibrils. The cytoplasm contained abundant
organelles, including rough endoplasmic reticulum cyster-
nae, free ribosomes and mitochondria, and intermediate
FIGURE 1. Densely cellular tumor in the intestinal wall (H&E,
original magnification 25 ). H&E indicates hematoxylin
and eosin.
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filaments. Several neoplastic cells presented peripheral
bundles of microfilaments with focal densities and subplas-
malemmal attachment plaques (Fig. 5). Adjacent neoplastic
cells were joined by immature junctions. Fibronexus
junctions were not observed.
Morphologic features along with immunohisto-
chemical, PCR, and ultrastructural results were consistent
with the diagnosis of congenital fibrosarcoma.
DISCUSSION
First recognized by Stout in the year 1962,7
congenital/infantile fibrosarcoma was widely studied by
Chung and Enzinger in 1976 and by Soule and Pritchard
in 1977.2,3 All these authors noted that, despite the
ominous morphology, congenital/infantile fibrosarcoma
had a more favorable behavior than its adult counterpart.
Most frequently, this tumor affects the extremities
(71% of cases) and the axial regions (29% of cases).8
Only few cases have been reported outside these regions.
Among the unusual localizations, there are the tongue
and the oral cavity, the ovary, the retroperitoneum, the
FIGURE 3. The proliferation index as determined by the
immunohistochemistry estimating the percentage of the Mib-
1 positive neoplastic cells in total tumoral cells in the most
positive areas was 15% (Mib-1 immunostain, original magni-
fication 100 ).
FIGURE 4. RT-PCR detection of the ETV6-NTRK3 chimeric
transcript. Ethidium bromide-stained agarose gel of PCR
products. Lane 1 indicates patient sample; lane 2, positive
control (111bp) from diagnosed congenital fibrosarcoma;
lane 3, size of ladder (700, 500, 400, 300, and 150bp); lane 4,
no-cDNA control. PCR indicates polymerase chain reaction;
RT, reverse transcriptase.
FIGURE 5. Electron Microscopy: neoplastic cell with myofi-
broblastic features, displaying a cytoplasm rich in RER
cysternae, free ribosomes, mitochondria, and intermediate
filaments. Peripheral bundles of actin filaments are indicated
by arrowheads. The cell is embedded in abundant extra-
cellular collagenous matrix. RER indicates rough endoplasmic
reticulum.
FIGURE 2. The tumor was composed of spindle cells forming
interlacing fascicles with herringbone appearance and small
amounts of interstitial collagen. Mitoses were appreciable.
(H&E, original magnification 200 ). H&E indicates hematox-
ylin and eosin.
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thoracic wall, the heart, and the intestine.9–13 To the best
of our knowledge, only 2 intestinal congenital/infantile
fibrosarcomas have been reported in the medical litera-
ture. In the year 1975, Shearburn et al14 described a
2-month-old baby girl with a duodenal congenital/infan-
tile fibrosarcoma causing duodenal obstruction. In the
year 2003, Shima et al15 reported a case of intestinal
perforation with consequent meconium peritonitis, as a
result of a congenital fibrosarcoma of the jejunum
in utero.
At the intestinal site, congenital/infantile fibrosar-
coma needs to be distinguished from other spindle cell
tumors, including GIST, leiomyosarcoma, spindle cell
rhabdomyosarcoma, MPNST, and myofibromatosis.
Overall, no specific immunohistochemical marker has
been identified for congenital/infantile fibrosarcoma and
therefore, the diagnosis needs the exclusion of these
entities with an appropriate panel of markers. Electron
microscopy can be a useful complement to demonstrate
fibroblastic/myofibroblastic differentiation of tumor cells
and to exclude other tumor types characterized by differ-
ent lines of differentiation.
GIST occurs rarely in children and the reported
cases showed mainly a spindle cell morphology, with
constant expression of CD117 and CD34,16,17 both
markers being negative in the present case. Leiomyosar-
coma is extremely rare in the pediatric age, although cases
involving the intestinal wall have been reported.18,19
Histologically, they show either a spindle or spindle and
epithelioid morphology, with strong immunoreactivity
for actin.16 Spindle cell rhabdomyosarcoma may be
difficult to distinguish from congenital/infantile fibrosar-
coma, but it occurs more frequently in the paratesticular
region and in the head and neck, and neoplastic cells are
positive for desmin and myogenin. In MPNST, neoplastic
cells show wavy nuclear contour, nuclear palisading, and
there are distinctly alternating hypercellular and hypo-
cellular zones. Infantile myofibromatosis with multi-
centric lesions may involve the small and large
intestines.20 Histologically, nodules of infantile myofibro-
matosis have a typical zonal appearance with central
cellular areas with hemangiopericytomatous appearance
and peripheral portions with distinct myofibroblastic
differentiation.
However, the definitive proof for the diagnosis of
congenital/infantile fibrosarcoma comes from molecular
analyses proving the ETV6-NTRK3 translocation, which
is particularly useful in cases arising at unusual sites, like
the intestinal tract. ETV6-NTRK3 is the product of a
t(12;15) (p13;q25) translocation that fuses the dimeriza-
tion domain of a transcriptional regulator (ETV6) with a
membrane receptor tyrosine kinase NTRK3. ETV6-
NTRK3 fusion protein has in vivo and in vitro
transforming activity in many cell lineages. Congenital/
infantile fibrosarcoma shares this molecular stigma with
some other morphologically different tumors such as
congenital mesoblastic nephroma and secretory breast
carcinoma.21–23 On the other hand, tumors morphologi-
cally similar to congenital/infantile fibrosarcomas do not
have ETV6-NTRK3 gene fusion. However, some authors
emphasized that the absence of ETV6-NTRK3 gene
fusion does not exclude the diagnosis of congenital/
infantile fibrosarcoma and argued that its absence
should be considered an unfavorable prognostic
factor.24,25
In conclusion, given the relatively indolent nature
of this disease despite the worrying morphology, it
is important to avoid misdiagnoses with more aggres-
sive tumors, particularly in the case of extraordinary
localization of the tumor. The diagnostic algorithm
for the diagnosis of congenital fibrosarcoma outside
the usual localizations should comprise morphologic,
immunohistochemical, molecular, and ultrastructural
studies.
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